Subscribe
Drug Pricing Theme Issue: Is Pharma Earning Too Much?, R&D Costs Required to Bring a New Drug to Market, Probiotic Safety, and more

JAMA Editor’s Summary

Drug Pricing Theme Issue: Is Pharma Earning Too Much?, R&D Costs Required to Bring a New Drug to Market, Probiotic Safety, and more

Editor's Summary by Gregory Curfman, MD, Deputy Editor of JAMA, the Journal of the American Medical Association, for the
March 3, 2020
ADVERTISEMENT
CNS Summit

Drug Pricing Theme Issue: Is Pharma Earning Too Much?, R&D Costs Required to Bring a New Drug to Market, Probiotic Safety, and more

Editor’s Summary by Gregory Curfman, MD, Deputy Editor of JAMA, the Journal of the American Medical Association, for the March 3, 2020 issue

ADVERTISEMENT
CNS Summit

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Proudly supported by:

cover
Mary Ellen Beliveau shares how her daughter’s battle with congenital heart disease drove her to improving the delivery of value-based care Join us as Mary Ellen talks about starting Knowledge to Practice (K2P) – a subscription-based educational platform that empowers frontline teams to deliver the best quality care to their patients.